OPK logo

OPK
Opko Health Inc

27,735
Mkt Cap
$888.11M
Volume
723.00
52W High
$1.75
52W Low
$1.10
PE Ratio
-3.87
OPK Fundamentals
Price
$1.15
Prev Close
$1.17
Open
$1.15
50D MA
$1.22
Beta
0.98
Avg. Volume
2.49M
EPS (Annual)
-$0.3004
P/B
0.70
Rev/Employee
$266,760.00
$974.14
Loading...
Loading...
News
all
press releases
Zacks Research Lowers Earnings Estimates for OPKO Health
OPKO Health, Inc. (NASDAQ:OPK - Free Report) - Zacks Research dropped their Q3 2026 earnings estimates for shares of OPKO Health in a report released on Thursday, March 19th. Zacks Research analyst...
MarketBeat·4d ago
News Placeholder
More News
News Placeholder
OPKO Health (NASDAQ:OPK) Director Buys $11,400.00 in Stock
OPKO Health, Inc. (NASDAQ:OPK - Get Free Report) Director John Paganelli bought 10,000 shares of OPKO Health stock in a transaction on Friday, March 20th. The shares were acquired at an average price of $1.14 per share, for a total transaction of $11,400.00. Following the completion of the...
MarketBeat·7d ago
News Placeholder
OPKO Health (NASDAQ:OPK) Sets New 12-Month Low - Should You Sell?
OPKO Health (NASDAQ:OPK) Sets New 52-Week Low - Here's Why...
MarketBeat·7d ago
News Placeholder
Zacks Research Forecasts OPKO Health FY2028 Earnings
OPKO Health, Inc. (NASDAQ:OPK - Free Report) - Equities researchers at Zacks Research issued their FY2028 earnings per share (EPS) estimates for OPKO Health in a research report issued to clients and...
MarketBeat·7d ago
News Placeholder
Here's Why You Should Hold OPK Stock in Your Portfolio for Now
OPK rides on RAYALDEE strength and partnerships, but revenue decline, losses, and reliance on a single drug cloud its near-term outlook.
Zacks·8d ago
News Placeholder
OPKO Health (NASDAQ:OPK) Downgraded to "Sell" Rating by Wall Street Zen
Wall Street Zen lowered shares of OPKO Health from a "hold" rating to a "sell" rating in a report on Saturday...
MarketBeat·20d ago
News Placeholder
HC Wainwright Has Weak Forecast for OPKO Health Q4 Earnings
OPKO Health, Inc. (NASDAQ:OPK - Free Report) - Stock analysts at HC Wainwright dropped their Q4 2026 earnings per share (EPS) estimates for OPKO Health in a note issued to investors on Monday, March...
MarketBeat·22d ago
News Placeholder
OPKO Health (NASDAQ:OPK) Given New $1.50 Price Target at Barrington Research
Barrington Research dropped their price objective on shares of OPKO Health from $2.25 to $1.50 and set an "outperform" rating for the company in a research note on Monday...
MarketBeat·25d ago
News Placeholder
OPK Q4 Earnings & Revenues Beat Estimates, Gross Margin Contracts
OPKO Health beats Q4 earnings and revenue estimates, but sales decline and gross margin narrows.
Zacks·28d ago
News Placeholder
OPKO Health Q4 Earnings Call Highlights
OPKO Health (NASDAQ:OPK) executives said the company exited 2025 with tremendous momentum, citing efforts to reposition its diagnostics business for a return to profitability, advance its ModeX...
MarketBeat·28d ago
<
1
2
...
>

Latest OPK News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.